.FDA rejects psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Accept MDMA Treatment, Seeking More Study The New York City TimesFDA Rejects Ecstasy-Based Medicine The Exchange JournalFDA refuses to authorize unique MDMA treatment to deal with PTSD, along with ask for more trial information CNNFDA turns down to begin with experimental to alleviate post-traumatic stress disorder, requiring additional research The Washington Message.